Stryker Neurovascular
Stryker
Hong Kong MDACSUnited States8 registered devicesSep 14, 2007 – Aug 08, 2024
VerifiedMDD (Medical Device Division) · MDACS registry
8
Total devices
2
Risk classes
2007
First registration
2024
Most recent
Applicant overview
- Applicant (EN)
- Stryker Neurovascular
- Applicant (ZH)
- Stryker
- Country
- United States
- Address
- 47900 Bayside Parkway, Fremont, California, 94538, USA
美国
47900 Bayside Parkway, Fremont, California, 94538, 美国
Timeline
- First registration
- Sep 14, 2007
- Most recent
- Aug 08, 2024
Regulatory footprint
Search Stryker Neurovascular across other regulatory registries
Risk class breakdown
II1
IV7
Recent MDACS registrations
Latest 15 devices linked to this applicant
Occluders, Vascular, Intravascular Embolization, Coil
封堵器,血管,血管内栓塞,线圈
Aug 08, 2024
- Risk class
- IV
- Authorised rep
- Synapse Therapeutics Limited百谷医疗科技有限公司
Stents, Vascular, Intracranial Artery, Aneurysm Flow Diversion
支架、血管、颅内动脉、动脉瘤血流分流
Jul 23, 2024
- Risk class
- IV
- Authorised rep
- Synapse Therapeutics Limited百谷医疗科技有限公司
Catheters
导管
Oct 03, 2012
- Risk class
- IV
- Authorised rep
- Stryker China Limited美国史赛克(中国)有限公司
Occluders, Vascular, Intravascular Embolization, Coil
封堵器,血管,血管内栓塞,线圈
Jul 31, 2012
- Risk class
- IV
- Authorised rep
- Stryker China Limited美国史赛克(中国)有限公司
Occluders, Vascular, Intravascular Embolization, Coil
封堵器,血管,血管内栓塞,线圈
Feb 08, 2011
- Risk class
- IV
- Authorised rep
- Stryker China Limited美国史赛克(中国)有限公司
Power Supplies
电源
Feb 08, 2011
- Risk class
- II
- Authorised rep
- Stryker China Limited美国史赛克(中国)有限公司
Stents, Vascular
支架,血管
Jan 18, 2011
- Risk class
- IV
- Authorised rep
- Stryker China Limited美国史赛克(中国)有限公司
Stents, Vascular
支架,血管
Sep 14, 2007
- Risk class
- IV
- Authorised rep
- Stryker China Limited美国史赛克(中国)有限公司
About this profile
Stryker Neurovascular is associated with 8 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.